EAM Investors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-49,656
Closed -$3.39M 360
2023
Q2
$3.39M Buy
49,656
+13,500
+37% +$871K 0.63% 31
2023
Q1
$1.75M Sell
36,156
-17,190
-32% -$908K 0.34% 138
2022
Q4
$3.21M Sell
53,346
-291
-0.5% -$17K 0.67% 30
2022
Q3
$3.25M Buy
+53,637
New +$1.7M 0.71% 20
2021
Q4
Sell
-64,650
Closed -$4.61M 357
2021
Q3
$4.61M Sell
64,650
-39,900
-38% -$2.48M 0.78% 8
2021
Q2
$5.38M Buy
104,550
+42,893
+70% +$1.34M 0.83% 2
2021
Q1
$1.55M Buy
+61,657
New +$1.16M 0.23% 206
2016
Q1
Sell
-63,746
Closed -$4.34M 331
2015
Q4
$4.34M Buy
63,746
+7,653
+14% +$462K 0.57% 28
2015
Q3
$2.54M Sell
56,093
-61,716
-52% -$3.59M 0.4% 96
2015
Q2
$6.21M Buy
117,809
+85,559
+265% +$3.38M 0.73% 7
2015
Q1
$1.23M Buy
+32,250
New +$827K 0.14% 276

Other funds holding PRTA

EAM Investors's PRTA Position: Q3 2023 in Review

EAM Investors sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 49,656 shares — an estimated $3.39M sold.

EAM Investors first reported a position in PRTA in Q1 2015 and held it in 11 quarters. The position peaked at $6.21M in Q2 2015. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • EAM Investors reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • EAM Investors sold 49,656 Prothena Corp shares in Q3 2023, an estimated $3.39M.
  • EAM Investors first reported a position in Prothena Corp in Q1 2015 and held it in 11 quarters.
  • EAM Investors's Prothena Corp position peaked at $6.21M in Q2 2015.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on EAM Investors's 13F filing for Q3 2023, filed 13 Nov 2023.